Karyopharm Therapeutics

$0.00 (0.00%) As of 11:00 AM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPTI and other ETFs, options, and stocks.

About KPTI

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. Its Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).

CEO
Richard A. Paulson
Employees
442
Headquarters
Newton, Massachusetts
Founded
2008

KPTI Key Statistics

Market cap
410.59M
Price-Earnings ratio
—
Dividend yield
—
Average volume
3.17M
High today
$5.26
Low today
$4.86
Open price
$5.15
Volume
2.48M
52 Week high
$14.73
52 Week low
$4.02

KPTI Earnings

-$0.77
-$0.36
$0.05
$0.46
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure